JP2012508744A5 - - Google Patents

Download PDF

Info

Publication number
JP2012508744A5
JP2012508744A5 JP2011536414A JP2011536414A JP2012508744A5 JP 2012508744 A5 JP2012508744 A5 JP 2012508744A5 JP 2011536414 A JP2011536414 A JP 2011536414A JP 2011536414 A JP2011536414 A JP 2011536414A JP 2012508744 A5 JP2012508744 A5 JP 2012508744A5
Authority
JP
Japan
Prior art keywords
less
suspension
particles
protein
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011536414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508744A (ja
JP5711138B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/063852 external-priority patent/WO2010056657A2/en
Publication of JP2012508744A publication Critical patent/JP2012508744A/ja
Publication of JP2012508744A5 publication Critical patent/JP2012508744A5/ja
Application granted granted Critical
Publication of JP5711138B2 publication Critical patent/JP5711138B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011536414A 2008-11-16 2009-11-10 高濃度の低粘度懸濁液 Expired - Fee Related JP5711138B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11508008P 2008-11-16 2008-11-16
US61/115,080 2008-11-16
PCT/US2009/063852 WO2010056657A2 (en) 2008-11-16 2009-11-10 Low viscosity highly concentrated suspensions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014247793A Division JP2015083582A (ja) 2008-11-16 2014-12-08 高濃度の低粘度懸濁液

Publications (3)

Publication Number Publication Date
JP2012508744A JP2012508744A (ja) 2012-04-12
JP2012508744A5 true JP2012508744A5 (cg-RX-API-DMAC7.html) 2013-02-21
JP5711138B2 JP5711138B2 (ja) 2015-04-30

Family

ID=42170660

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011536414A Expired - Fee Related JP5711138B2 (ja) 2008-11-16 2009-11-10 高濃度の低粘度懸濁液
JP2014247793A Pending JP2015083582A (ja) 2008-11-16 2014-12-08 高濃度の低粘度懸濁液

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014247793A Pending JP2015083582A (ja) 2008-11-16 2014-12-08 高濃度の低粘度懸濁液

Country Status (7)

Country Link
US (2) US8779094B2 (cg-RX-API-DMAC7.html)
EP (1) EP2376522A4 (cg-RX-API-DMAC7.html)
JP (2) JP5711138B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110103961A (cg-RX-API-DMAC7.html)
CA (1) CA2743789C (cg-RX-API-DMAC7.html)
IL (1) IL212919A (cg-RX-API-DMAC7.html)
WO (1) WO2010056657A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5658031B2 (ja) 2007-06-22 2015-01-21 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 薄膜凍結による安定したサブミクロンのペプチド又はタンパク質粒子の形成
CN103096934A (zh) * 2010-03-09 2013-05-08 詹森生物科技公司 非水性高浓度低粘度混悬剂
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
US20110223208A1 (en) * 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
US9445990B2 (en) * 2010-10-06 2016-09-20 Medtronic, Inc. TNF inhibitor formulation for use in implantable infusion devices
AU2012225277A1 (en) * 2011-03-10 2013-09-26 Board Of Regents, The University Of Texas System Protein nanoparticle dispersions
CN108771655A (zh) * 2011-10-28 2018-11-09 诚信生物公司 含有氨基酸的蛋白质制剂
EP2776091B1 (en) 2011-11-07 2021-03-03 Battelle Memorial Institute Processes for delivery of viscous drug therapies
SG10201709555SA (en) * 2012-05-18 2017-12-28 Genentech Inc High-concentration monoclonal antibody formulations
US20140342006A1 (en) * 2013-03-15 2014-11-20 Ansun Biopharma, Inc. Methods for Preparing Injectable Protein Microparticle Suspensions
IL312865B2 (en) 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
CN103976947B (zh) * 2014-06-05 2016-08-17 段明星 一种含酶油悬浮剂及其制备方法与应用
KR102497368B1 (ko) * 2014-10-01 2023-02-10 이글 바이올로직스 인코포레이티드 점도-저하제를 함유하는 폴리삭카라이드 및 핵산 제형
CN107743396B (zh) 2014-12-12 2021-01-15 Motejo股份有限公司 皮下注射用剂
JP5774190B1 (ja) * 2014-12-12 2015-09-09 ジーンメディカル株式会社 皮下注射用剤及び皮下注射用剤を含有する注射器の製造方法
US11459401B2 (en) * 2016-10-06 2022-10-04 Amgen Inc. Reduced viscosity protein pharmaceutical formulations
EP3544724A4 (en) 2016-11-22 2020-10-14 Elektrofi, Inc PARTICLES INCLUDING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND THEIR METHODS OF USE
WO2019023392A1 (en) 2017-07-25 2019-01-31 Elektrofi, Inc. FORMATION OF PARTICLES COMPRISING AGENTS
US12115262B2 (en) 2018-05-24 2024-10-15 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
KR102051808B1 (ko) 2018-07-23 2019-12-04 주식회사 종근당 테스토스테론 운데카노에이트를 포함하는 안정한 약제학적 조성물
AU2020214626B2 (en) 2019-01-31 2025-10-16 Elektrofi, Inc. Particle formation and morphology
KR20210125032A (ko) 2019-02-05 2021-10-15 린디 바이오사이언시스, 아이엔씨. 세포 배양 성분 및 액체 세포 배양 배지로부터 이를 단리하는 방법
US20200376128A1 (en) * 2019-06-01 2020-12-03 Lupin Holdings B.V. Monodisperse resorbable polyester polymer compositions, systems, and methods
AU2020344675A1 (en) * 2019-09-13 2022-03-31 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
JP2023522627A (ja) 2020-04-17 2023-05-31 エレクトロフィ，インコーポレイテッド 連続的な液滴形成及び脱水によって粒子を形成する方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795516A (fr) 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
US4310516A (en) 1980-02-01 1982-01-12 Block Drug Company Inc. Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
EP0079143A3 (en) 1981-10-20 1984-11-21 Adnovum Ag Pseudoplastic gel transfer
US4594108A (en) 1983-09-19 1986-06-10 The Dow Chemical Company Highly pseudoplastic polymer solutions
US5411951A (en) 1984-10-04 1995-05-02 Monsanto Company Prolonged release of biologically active somatotropin
US5288479A (en) 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
SE465950B (sv) 1989-10-23 1991-11-25 Medinvent Sa Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning
US5300302A (en) 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
YU87892A (sh) 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
AU3941493A (en) 1992-03-30 1993-11-08 Alza Corporation Viscous suspensions of controlled-release drug particles
US5571525A (en) 1992-03-30 1996-11-05 Alza Corporation Erosion rate modifier for use in bioerodible drug delivery devices and method of use
US5512293A (en) 1992-07-23 1996-04-30 Alza Corporation Oral sustained release drug delivery device
SE9203594D0 (sv) 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
DE69431533T2 (de) 1994-06-13 2003-10-02 Alza Corp., Palo Alto Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
US5904935A (en) 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
AU737664B2 (en) 1996-07-03 2001-08-30 Alza Corporation Non-aqueous protic peptide formulations
US5932547A (en) 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
US5916582A (en) 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
IN184589B (cg-RX-API-DMAC7.html) 1996-10-16 2000-09-09 Alza Corp
US7393630B2 (en) 1997-12-16 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Use of microparticles combined with submicron oil-in-water emulsions
ATE322889T1 (de) 1999-02-08 2006-04-15 Alza Corp Stabile nicht wässerige einphasige visköse vehikeln und formulierungen die diese vehikeln verwenden
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
FR2809309B1 (fr) * 2000-05-23 2004-06-11 Mainelab Microspheres a liberation prolongee pour administration injectable
DE60138641D1 (de) 2000-10-27 2009-06-18 Baxter Healthcare Sa Herstellung von mikrokügelchen
US20040022861A1 (en) * 2001-01-30 2004-02-05 Williams Robert O. Process for production of nanoparticles and microparticles by spray freezing into liquid
JP4724354B2 (ja) * 2001-02-23 2011-07-13 ジェネンテック， インコーポレイテッド 注射用の崩壊性ポリマー
AU2002322295C1 (en) * 2001-06-21 2008-12-18 Altus Pharmaceuticals Inc. Spherical protein particles and methods of making and using them
EP1578394A4 (en) 2002-12-31 2011-02-23 Nektar Therapeutics ANTIBODY PARTICLES AND COMPOSITIONS
BRPI0403964B8 (pt) * 2003-04-04 2021-05-25 Genentech Inc formulações líquidas estáveis, artigo manufaturado e uso dessas formulações para o tratamento de disfunção mediada por ige
CA2540695A1 (en) * 2003-06-24 2004-12-29 Baxter International Inc. Specific delivery of drugs to the brain
KR101137785B1 (ko) 2003-07-18 2012-04-25 백스터 인터내셔널 인코포레이티드 제어된 상 분리에 의해 제조된 작은 구형 입자의 제조방법, 이용 방법 및 조성물
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
MXPA06012992A (es) 2004-05-12 2007-02-12 Baxter Int Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
US20060141040A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2006083761A2 (en) * 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US20070015689A1 (en) 2005-06-23 2007-01-18 Alza Corporation Complexation of metal ions with polypeptides
AU2006330627A1 (en) 2005-12-16 2007-07-05 University Of Kansas Nanoclusters for delivery of therapeutics
US20090304599A1 (en) 2005-12-20 2009-12-10 Fujifilm Corporation Protein Nanoparticles and the Use of the Same
US20080102128A1 (en) * 2006-07-28 2008-05-01 Flamel Technologies, Inc. Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
JP5658031B2 (ja) * 2007-06-22 2015-01-21 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 薄膜凍結による安定したサブミクロンのペプチド又はタンパク質粒子の形成
CN101081882A (zh) * 2007-07-06 2007-12-05 天津大学 大分子印迹交联聚乙烯基吡咯烷酮微球及低温悬浮聚合制备方法
JP2009173610A (ja) 2008-01-28 2009-08-06 Fujifilm Corp タンパク質ナノ粒子
BRPI0909780B1 (pt) 2008-03-05 2022-05-03 Baxter International Inc Suspensão contendo uma partícula com superfície modificada, composição farmacêutica compreendendo a referida suspensão, método para aprimorar a absorção celular de um agente ativo, uso de partículas com superfície modificada, e método de preparação de uma partícula com superfície modificada
RU2010146684A (ru) 2008-05-09 2012-06-20 Саут Дакота Стейт Юниверсити (US) Способ получения неиммуногенных гидрофобных белковых наночастиц и их применения
US20100009007A1 (en) 2008-07-10 2010-01-14 Baxter International Inc. Non-covalent modification of microparticles and process of preparing same
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
WO2010100200A2 (en) 2009-03-05 2010-09-10 Novartis Ag Lyophilised antibody formulation

Similar Documents

Publication Publication Date Title
JP5711138B2 (ja) 高濃度の低粘度懸濁液
JP2012508744A5 (cg-RX-API-DMAC7.html)
AU2025210802B2 (en) Formation of particles including agents
DK2806886T3 (en) STABILIZED PROTEIN COMPOSITIONS BASED ON SEMIFLUORED ALKANES
JP7761562B2 (ja) 非水性溶媒で懸濁されたタンパク質粒子を含む懸濁製剤
CN103402540A (zh) 抗体的非水性高浓度低粘度混悬剂
CN102802624A (zh) 药物的纳米分散体以及它的制备方法
CN112494492B (zh) 阿立哌唑前体药物组合物
Moebus et al. Cubic phase-forming dry powders for controlled drug delivery on mucosal surfaces
TWI745358B (zh) 含有細微粒子之組合物及其製法
CN103096934A (zh) 非水性高浓度低粘度混悬剂
JP2013209406A (ja) 金属イオンとポリペプチドとの錯化
TW202440161A (zh) 可注射聚合生物醫藥配製物
CN101022833B (zh) 甘油二棕榈酸硬脂酸酯用于提高皮下或肌肉注射制剂中的蛋白质活性成分的生物利用度的用途
US20260000611A1 (en) Hyaluronic acid derivative pharmaceutical composition and pharmaceutical composition
Miller Highly concentrated, nanoclusters of self-crowded monoclonal antibodies for low viscosity, subcutaneous injections
HK1182323A (en) Non-aqueous high concentration reduced viscosity suspension formulations